Kun Xia Selected Research

Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)

2/2014	A novel transgenic mouse model of Chinese Charcot-Marie-Tooth disease type 2L.
11/2012	Rapid genetic screening of Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies patients.
8/2010	[Mutation analysis of LITAF, RAB7, LMNA and MTMR2 genes in Chinese Charcot-Marie-Tooth disease.].
12/2006	[Study on aggregate formation mechanism of HSPB8 gene mutation resulting in CMT2L].
10/2005	[Mutation analysis of small heat shock protein 27 gene in Chinese patients with Charcot-Marie-Tooth disease].
10/2005	[Detection of duplications or deletions of the PMP22 gene using real-time quantitative PCR].
8/2005	Mutation analysis of the small heat shock protein 27 gene in chinese patients with Charcot-Marie-Tooth disease.
8/2005	Mutation analysis of small heat-shock protein 22 gene in Chinese patients with Charcot-Marie-Tooth disease.
2/2005	Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L.
6/2004	[Mutation analysis of ganglioside-induced differentiation associated protein-1 gene in Chinese Charcot-Marie-Tooth disease].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kun Xia Research Topics

Disease

25	Neoplasms (Cancer) 05/2022 - 12/2004
13	Parkinson Disease (Parkinson's Disease) 01/2021 - 06/2006
11	Myocardial Infarction 12/2022 - 04/2007
11	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 03/2011
11	Autistic Disorder (Autism) 01/2021 - 10/2014
11	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 02/2014 - 10/2002
10	Squamous Cell Carcinoma of Head and Neck 05/2022 - 04/2008
9	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2019 - 06/2005
8	ST Elevation Myocardial Infarction 01/2021 - 06/2007
8	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2008
7	Autism Spectrum Disorder 07/2022 - 01/2015
7	Inflammation (Inflammations) 01/2022 - 08/2009
7	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2016 - 10/2008
6	Melanoma (Melanoma, Malignant) 06/2022 - 11/2012
6	Ataxia (Dyssynergia) 01/2022 - 06/2011
6	Thrombosis (Thrombus) 12/2015 - 04/2007
6	Hearing Loss (Hearing Impairment) 10/2010 - 09/2004
5	Carcinoma (Carcinomatosis) 09/2021 - 04/2008
5	Multiple System Atrophy 01/2021 - 02/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 12/2015 - 12/2008
5	Parkinsonian Disorders (Parkinsonism) 01/2015 - 09/2010
5	Cerebellar Ataxia (Dysmetria) 01/2015 - 04/2005
5	Deafness (Deaf Mutism) 10/2011 - 04/2002
4	Hypoxia (Hypoxemia) 05/2022 - 06/2006
4	Neurodevelopmental Disorders 01/2022 - 12/2019
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2014
4	Myopia 01/2021 - 01/2014
4	Carcinogenesis 12/2020 - 06/2007
4	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 02/2006
4	Hereditary Spastic Paraplegia 01/2014 - 06/2003
3	Necrosis 01/2021 - 12/2012
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2021 - 01/2015
3	Wounds and Injuries (Trauma) 10/2020 - 04/2017
3	Infections 01/2020 - 04/2005
3	Retinitis Pigmentosa (Pigmentary Retinopathy) 03/2015 - 04/2003
3	Hemorrhage 03/2014 - 06/2007
3	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 06/2011 - 10/2008
2	Type 2 Diabetes Mellitus (MODY) 05/2022 - 12/2020
2	Pulmonary Alveolar Proteinosis 01/2022 - 01/2022
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 10/2017
2	Osteoporosis 12/2021 - 10/2021
2	Oral Submucous Fibrosis 11/2020 - 03/2018
2	Burns 10/2020 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 04/2006
2	Fragile X Syndrome (Martin Bell Syndrome) 01/2020 - 03/2003
2	Intellectual Disability (Idiocy) 01/2020 - 03/2003
2	Atherosclerosis 06/2019 - 10/2013

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2004
13	Biomarkers (Surrogate Marker)IBA 07/2022 - 02/2014
10	DNA (Deoxyribonucleic Acid)IBA 10/2016 - 02/2006
8	Biological ProductsIBA 07/2021 - 04/2008
7	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2014
6	omega-Chloroacetophenone (Mace)IBA 12/2022 - 06/2007
6	Messenger RNA (mRNA)IBA 05/2022 - 06/2006
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2021 - 08/2009
5	Small Heat-Shock ProteinsIBA 12/2006 - 02/2005
4	ConnexinsIBA 03/2016 - 04/2002
4	Levodopa (L Dopa)FDA LinkGeneric 01/2015 - 06/2005
4	Nonsense Codon (Nonsense Mutation)IBA 08/2014 - 12/2008
4	TransglutaminasesIBA 10/2013 - 01/2013
4	human GJB3 proteinIBA 10/2011 - 06/2005
3	Cadherins (E-Cadherin)IBA 05/2022 - 11/2020
3	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 01/2017
3	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2014
3	CollagenIBA 01/2022 - 04/2015
3	Immunoglobulin A (IgA)IBA 08/2021 - 04/2005
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2014
3	LipidsIBA 06/2019 - 08/2017
3	polyglutamineIBA 01/2019 - 01/2013
3	Sirolimus (Rapamycin)FDA Link 03/2016 - 04/2007
3	Myelin ProteinsIBA 07/2015 - 10/2005
3	Complementary DNA (cDNA)IBA 06/2015 - 03/2003
3	Tirofiban (Aggrastat)FDA Link 03/2014 - 06/2007
3	Ataxin-3IBA 12/2013 - 06/2005
3	Keratin-9 (Keratin 9)IBA 03/2007 - 12/2004
2	LigandsIBA 06/2022 - 09/2021
2	Histone MethyltransferasesIBA 01/2022 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 01/2020
2	GalactosidasesIBA 10/2021 - 01/2016
2	InterleukinsIBA 08/2021 - 04/2016
2	Interleukin-6 (Interleukin 6)IBA 08/2021 - 04/2016
2	Immunoglobulins (Immunoglobulin)IBA 08/2021 - 01/2021
2	AntibodiesIBA 08/2021 - 05/2013
2	CytokinesIBA 01/2021 - 12/2020
2	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 01/2021 - 09/2019
2	Superoxide DismutaseIBA 12/2020 - 01/2020
2	Malondialdehyde (Propanedial)IBA 12/2020 - 01/2020
2	SilverIBA 10/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2020 - 11/2008
2	Amyloid (Amyloid Fibrils)IBA 01/2020 - 03/2011
2	Sirtuin 1IBA 01/2020 - 04/2016
2	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 08/2007

Therapy/Procedure

9	Percutaneous Coronary Intervention 01/2021 - 06/2007
8	Therapeutics 06/2022 - 12/2004
6	Stents 12/2015 - 04/2007
4	Immunotherapy 06/2022 - 01/2020
3	Precision Medicine 01/2021 - 01/2015
3	Ligation 01/2020 - 06/2011
2	Nephroureterectomy 09/2021 - 01/2021
2	Intravenous Injections 01/2021 - 01/2020